Expression of mitotic-arrest deficiency 2 predicts the efficacy of neoadjuvant chemotherapy for locally advanced uterine cervical cancer

By                    

Experimental and Therapeutic Medicine, Vol. 3, Iss. 2, 2012-01 ,pp. : 341-346

Spandidos Publications

Access to resources Recommend Favorite

Mitotic arrest deficiency 2 induces carcinogenesis in mucinous ovarian tumors

By                  

Oncology Letters, Vol. 3, Iss. 2, 2012-01 ,pp. : 281-286

Spandidos Publications

Access to resources Recommend Favorite

CRABP1-reduced expression is associated with poorer prognosis in serous and clear cell ovarian adenocarcinoma

By Miyake Takahito   Ueda Yutaka   Matsuzaki Shinya   Miyatake Takashi   Yoshino Kiyoshi   Fujita Masami   Nomura Taisei   Enomoto Takayuki   Kimura Tadashi  

Journal of Cancer Research and Clinical Oncology, Vol. 137, Iss. 4, 2011-04 ,pp. : 715-722

Springer Publishing Company

Access to resources Recommend Favorite

Resistance to first line platinum paclitaxel chemotherapy in serous epithelial ovarian cancer: The prediction value of ERCC1 and Tau expression

By                

International Journal of Oncology, Vol. 44, Iss. 5, 2014-01 ,pp. : 1736-1744

Spandidos Publications

Access to resources Recommend Favorite

Overcoming Chemotherapy Resistance in High Grade Serous Ovarian Cancer

By  

Current Cancer Therapy Reviews, Vol. 12, Iss. 1, 2016-10 ,pp. : 23-36

Bentham Science Publishers

Access to resources Recommend Favorite